Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Phase 1 study of single-agent WNT974, a first-in-class Porcupine inhibitor, in patients with advanced solid tumours
Jordi Rodón, Guillem Argilés, Roisín M. Connolly, et al.
British Journal of Cancer (2021) Vol. 125, Iss. 1, pp. 28-37
Open Access | Times Cited: 108

Showing 1-25 of 108 citing articles:

Mechanisms and inhibition of Porcupine-mediated Wnt acylation
Yang Liu, Xiaofeng Qi, Linda Donnelly, et al.
Nature (2022) Vol. 607, Iss. 7920, pp. 816-822
Open Access | Times Cited: 69
Wnt pathway modulators in cancer therapeutics: An update on completed and ongoing clinical trials
Ann Neiheisel, Manpreet Kaur, Nancy Ma, et al.
International Journal of Cancer (2021) Vol. 150, Iss. 5, pp. 727-740
Open Access | Times Cited: 71
The strategies to cure cancer patients by eradicating cancer stem-like cells
Yansui Mai, Jiyan Su, Chuan Yang, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 38
A Phase Ib/II Study of WNT974 + Encorafenib + Cetuximab in Patients With BRAFV600E-MutantKRASWild-Type Metastatic Colorectal Cancer
Josep Tabernero, Eric Van Cutsem, Elena Garralda, et al.
The Oncologist (2023) Vol. 28, Iss. 3, pp. 230-238
Open Access | Times Cited: 31
A New Wave of Targeting ‘Undruggable’ Wnt Signaling for Cancer Therapy: Challenges and Opportunities
Woo Jung Park, Moon Jong Kim
Cells (2023) Vol. 12, Iss. 8, pp. 1110-1110
Open Access | Times Cited: 29
Wnt/β-catenin Signaling Inhibitors
Xun Zhang, Nazhen Dong, Xiaoyan Hu
Current Topics in Medicinal Chemistry (2023) Vol. 23, Iss. 10, pp. 880-896
Closed Access | Times Cited: 27
Profiling and targeting cancer stem cell signaling pathways for cancer therapeutics
Mia C. Borlongan, Hongbin Wang
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 23
Protein lipidation in cancer: mechanisms, dysregulation and emerging drug targets
Edward W. Tate, Lior Soday, Ana Losada de la Lastra, et al.
Nature reviews. Cancer (2024) Vol. 24, Iss. 4, pp. 240-260
Closed Access | Times Cited: 14
Informed by Cancer Stem Cells of Solid Tumors: Advances in Treatments Targeting Tumor-Promoting Factors and Pathways
Maya R. MacLean, Olivia L. Walker, Raj Pranap Arun, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 4102-4102
Open Access | Times Cited: 13
Cancer associated fibroblasts serve as an ovarian cancer stem cell niche through noncanonical Wnt5a signaling
Yiming Fang, Xue Xiao, Ji Wang, et al.
npj Precision Oncology (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 10
Digestive cancers: mechanisms, therapeutics and management
Tianzuo Zhan, Johannes Betge, Nadine Schulte, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 1
WNT Signaling as a Therapeutic Target for Glioblastoma
Michael Latour, Nam-Gu Her, Santosh Kesari, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 16, pp. 8428-8428
Open Access | Times Cited: 48
Loss of Rnf43 Accelerates Kras-Mediated Neoplasia and Remodels the Tumor Immune Microenvironment in Pancreatic Adenocarcinoma
Abdel Hosein, Gita Dangol, Takashi Okumura, et al.
Gastroenterology (2021) Vol. 162, Iss. 4, pp. 1303-1318.e18
Open Access | Times Cited: 42
Blocking the Wnt/β‑catenin signaling pathway to treat colorectal cancer: Strategies to improve current therapies (Review)
Yuxiang Chen, Mo Chen, Kai Deng
International Journal of Oncology (2022) Vol. 62, Iss. 2
Open Access | Times Cited: 36
Wnt Signaling Inhibitors and Their Promising Role in Tumor Treatment
Nives Pećina‐Šlaus, Sara Aničić, Anja Bukovac, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6733-6733
Open Access | Times Cited: 20
The Roles of Secreted Wnt Ligands in Cancer
Johannes Werner, Kim E. Boonekamp, Tianzuo Zhan, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5349-5349
Open Access | Times Cited: 19
Preclinical and Clinical Trials of New Treatment Strategies Targeting Cancer Stem Cells in Subtypes of Breast Cancer
Natalia Landeros, Iván Castillo, Ramón Pérez-Castro
Cells (2023) Vol. 12, Iss. 5, pp. 720-720
Open Access | Times Cited: 16
Dysfunction of dendritic cells in tumor microenvironment and immunotherapy
Jie Chen, Yu-Hang Duan, Junye Che, et al.
Cancer Communications (2024) Vol. 44, Iss. 9, pp. 1047-1070
Open Access | Times Cited: 7
Signaling pathways in colorectal cancer implications for the target therapies
Yanlin Song, Ming Chen, Yuhao Wei, et al.
Molecular Biomedicine (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 6
RNF 43 truncations trap CK 1 to drive niche‐independent self‐renewal in cancer
Maureen Spit, Nicola Fenderico, Ingrid Jordens, et al.
The EMBO Journal (2020) Vol. 39, Iss. 18
Open Access | Times Cited: 41
Carboxylesterase Notum Is a Druggable Target to Modulate Wnt Signaling
Elliott D. Bayle, Fredrik Svensson, Benjamin N. Atkinson, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 8, pp. 4289-4311
Open Access | Times Cited: 37
Therapeutic Potential of Naturally Occurring Small Molecules to Target the Wnt/β-Catenin Signaling Pathway in Colorectal Cancer
Luiz Fernando Silva Oliveira, Danilo Predes, Helena L. Borges, et al.
Cancers (2022) Vol. 14, Iss. 2, pp. 403-403
Open Access | Times Cited: 27
A p300/GATA6 axis determines differentiation and Wnt dependency in pancreatic cancer models
Zheng Zhong, Nathan Harmston, Kris C. Wood, et al.
Journal of Clinical Investigation (2022) Vol. 132, Iss. 12
Open Access | Times Cited: 22
Wnt signaling and tumors (Review)
Huaishi Wang, Lihai Zhang, Chao Hu, et al.
Molecular and Clinical Oncology (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 5
Wnt signaling drives stromal inflammation in inflammatory arthritis
Alisa A. Mueller, Angela E. Zou, Lucy‐Jayne Marsh, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Page 1 - Next Page

Scroll to top